Please download a copy of the letter below and read it fully. If you believe you are suitable for AHSCT treatment, then follow the instructions below. Please check against the above eligibility criteria first. The procedure is high risk so if your neurologist is advising against AHSCT it may be because it is unlikely to be effective in your circumstances based on current research. If you are interested in AHSCT you should speak to your neurologist before contacting the team at Sheffield Teaching Hospitals NHS Foundation Trust. These were people with very aggressive relapsing remitting multiple sclerosis, who had very frequent and severe relapses which could not be controlled with disease modifying drugs, who we think have the best chance of success with this treatment.
#STEM CELL TREATMENT FOR MULTIPLE SCLEROSIS TRIAL#
If you and your neurologist feel that you have primary or secondary progressive multiple sclerosis it is very unlikely that AHSCT will be helpful for you, and we are not able to offer treatment for these patients.Ī small number of people have been treated at Sheffield Teaching Hospitals NHS Foundation Trust with AHSCT outside of a clinical trial setting. In view of this data, at Sheffield Teaching Hospitals NHS Trust we are only treating people with relapsing remitting multiple sclerosis. Unfortunately the trials performed to date show that AHSCT does not work well in primary and secondary progressive multiple sclerosis. People with highly active relapsing-remitting MS seem to have the best response to the treatment. Completed referral form from your Consultant Neurologist, GP, or equivalent Medical PractitionerĬlinical trials conducted so far suggest that AHSCT may be able reduce relapses and to stabilise or reduce the level of disability for some people with relapsing remitting multiple sclerosis.Have Multiple Sclerosis-Active Relapsing Remitting.
0 kommentar(er)
